Analyst Ratings for Hemab Therapeutics Holdings (COAG)
COAG Rating Summary
COAG Price Target Summary
- Highest: $52.00 (H.C. Wainwright)
- Lowest: $36.00 (Goldman Sachs)
- Average: $44.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$44.25 (-10.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/17/2026 | H.C. Wainwright » Updated 7/13/2026 |
Emily Bodnar | New Coverage | Buy (N/A) |
52.00 (40.00) |
25.51 (49.29) |
93.22% | Details |
| 5/26/2026 | Evercore ISI | Cory K | New Coverage | Outperform (N/A) |
N/A (N/A) |
25.89 (49.29) |
90.38% | Details |
 |
||||||||
|
||||||||
|
||||||||
